Under steady-state conditions, most tissue-resident macrophages in the peritoneal cavity and liver are derived from embryonic precursors seeded during fetal development. These fetal-derived macrophages maintain themselves in the tissues through self-renewal, independent of bone marrow hematopoiesis^[@R1]^. However, at some mucosal surfaces, especially the intestine^[@R2]^, there is a significant contribution of monocyte-derived macrophages that are of bone marrow origin, indicating that exposure to the environment may increase the rate of macrophage replenishment from monocytes even under homeostatic conditions. During an inflammatory response, macrophages that infiltrate the tissues in response to pathogens are derived from blood monocytes^[@R3],\ [@R4]^. The fate of these inflammatory macrophages, and whether they eventually adopt a tissue-resident macrophage phenotype, is unclear. The tissue environment was shown to significantly influence the phenotype of transplanted mature macrophages^[@R5],\ [@R6]^, and monocytes can occupy the niche of tissue-resident macrophages when it becomes available^[@R7],\ [@R8]^. However, the mechanisms that enable the conversion of monocytes into tissue-resident macrophages are unknown and may be tissue specific.

Granulomas are organized structures made of macrophages recruited during an inflammatory response. The liver granulomas that form around the extracellular eggs of the multicellular trematode *Schistosoma mansoni* are driven by a type2 immune response^[@R9]^, and are critical in limiting the amount of tissue damage and hepatotoxicity and for the survival of the mammalian host ^[@R10],\ [@R11]^. The macrophages in these granulomas respond to interleukin 4 (IL-4) and/or IL-13 through IL-4R-and STAT6-mediated signaling to adopt an *Arg1*^+^*Retnla*^+^*Chi3l3*^+^ alternatively activated macrophage phenotype^[@R12],\ [@R13]^ (hereafter referred to as AAM, unless otherwise specified). Macrophage and neutrophil-specific IL-4Rα-deficient mice, which lack AAM, die during acute *S. mansoni* infection^[@R14]^. These AAMs are also PD-L2^+^CD206^+^ and are derived from inflammatory Ly6C^hi^ monocytes^[@R15],\ [@R16]^, which in turn are dependent on expression of CCR2^[@R16]^ and on CD4^+^ T helper cells^[@R15]^ for recruitment into tissues. In some cases, such as infection with the filarial nematode *Litomosoides sigmodontis*^[@R17]^ or the gastrointestinal nematode *Heligmosomoides polygyrus*^[@R18]^, AAMs can also derive from F4/80^hi^CD206^−^ tissue-resident macrophages that expand through proliferation. IL-4 can induce the proliferation and the expression of *Arg1, Retnla* and *Chi3l3* in macrophages regardless of their embryonic or adult bone marrow origin^[@R19]^. Hence, type 2 immune responses can induce AAM derived from either Ly6C^hi^ monocytes or F4/80^hi^CD206^−^ tissue-resident macrophages. These *in vivo*-derived AAM have a gene expression phenotype similar to bone marrow derived macrophages activated with IL-4 *in vitro* (often referred to as M2 macrophages), namely expression of *Arg1*, *Retnla* and *Chi3l3*^[@R12]^. Arginase1 (encoded by *Arg1*) in particular inhibits fibrosis and type 2 inflammation in the liver during *S. mansoni* infection^[@R20]^.

AAMs derived from the proliferation of local F4/80^hi^CD206^−^ tissue-resident macrophages are phenotypically distinct from AAMs derived through recruitment of Ly6C^hi^monocytes. Monocyte-derived AAMs express the costimulatory ligand PD-L2 and can induce the differentiation of CD4^+^Foxp3^+^ T~reg~ cells via retinoic acid, whereas F4/80^hi^CD206^−^ tissue-resident macrophages are PD-L2-negative and upregulate the mitochondrial thermogenic protein UCP1^[@R19]^. As acute inflammation transitions to chronic inflammation in the tissue, inflammatory macrophages may adopt the phenotype of tissue-resident macrophages^[@R21],\ [@R22]^.

Vitamin A deficiency is a common micronutrient deficiency, often affecting individuals in regions of the world endemic for chronic helminth infections^[@R23]^. Retinoic acid is a metabolite of vitamin A that has multiple roles in regulating both innate and adaptive immunity^[@R24]^, including activation of the transcription factor GATA6^[@R25]^ to induce differentiation of F4/80^hi^ peritoneal macrophages. Here, we show that vitamin A was required for the conversion of monocyte-derived F4/80^int^CD206^+^PD-L2^+^MHCII^+^ macrophages into a tissue resident F4/80^hi^CD206^−^PD-L2^−^MHCII^−^UCP1^+^ macrophage phenotype in the peritoneal cavity and in liver granulomas during *S. mansoni* infection.

RESULTS {#S1}
=======

Conversion of AAM^mono^ into a tissue resident AAM^res^ phenotype {#S2}
-----------------------------------------------------------------

Injection of recombinant IL-4 complex (IL-4c) into the peritoneal cavity of C57BL/6 mice induces accumulation of F4/80^hi^CD206^−^PD-L2^−^MHCII^−^UCP1^+^ macrophages, which are derived from tissue-resident F4/80^hi^CD206^−^ peritoneal macrophages of embryonic origin^[@R19]^, while injection of IL-4c and thioglycollate (Thio) induces the accumulation of F480^int^CD206^+^PD-L2^+^MHCII^+^ cells, which derive from Ly6C^hi^ inflammatory blood monocytes^[@R19]^. To investigate if inflammatory macrophages can undergo phenotypic conversion into a tissue-resident macrophage phenotype, we sorted F480^int^CD206^+^PD-L2^+^MHCII^+^cells (hereafter referred to as AAM^mono^, unless otherwise specified) from Thio+IL-4c-treated CD45.1 C57BL/6 mice and transferred them through intraperitoneal injection into CD45.2 C57BL/6 mice untreated or treated with two doses of IL-4c over 4 days. Transferred peritoneal CD45.1^+^C57BL/6 AAM^mono^ cells downregulated the expression of PD-L2 after transfer in untreated, but not in IL-4c-treated recipient mice, whereas expression of CD206 was maintained in both hosts ([Fig. 1a](#F1){ref-type="fig"}), indicating that expression of PD-L2 on AAM^mono^ was modulated and sensitive to the continued presence of IL-4 *in vivo*, whereas expression of CD206 and MHC class II ([Supplementary Fig. 1a--c](#SD1){ref-type="supplementary-material"}) was maintained in this time frame. CD11b^+^F4/80^hi^CD206^+^ macrophages isolated from Thio-treated mice, which do not express PD-L2, induced expression of PD-L2 after two doses of IL-4c treatment over 4 days of the recipient mice, but not in untreated recipients ([Supplementary Fig. 1a--c](#SD1){ref-type="supplementary-material"}).

We also transferred F4/80^hi^CD206^−^PD-L2^−^MHCII^−^UCP1^+^ macrophages (hereafter referred to as AAM^res^, unless otherwise specified) from IL-4c-treated CD45.1 C57BL/6 mice into the peritoneal cavity of recipient CD45.2 C57BL/6 mice. The AAM^res^ phenotype was maintained in the peritoneal cavity for 5 days on CD45.1^+^ donor macrophages transferred into IL-4c-treated or untreated recipient mice ([Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}). However, following transfer into mice treated with Thio+IL-4c 24hrs after transfer, donor CD45.1^+^AAM^res^ cells could not be detected in the peritoneal cavity of recipient mice 4 days later ([Supplementary Fig. 1e](#SD1){ref-type="supplementary-material"}), an observation that could be reminiscent of the macrophage disappearance reaction of tissue-resident F4/80^hi^ peritoneal macrophages^[@R26]^.

In time-course experiments, one week post a single intraperitoneal injection with Thio or Thio+IL-4c into wild-type C57/BL6 mice, CD11b^+^ macrophages were F4/80^int^CD206^+^, whereas 4 weeks after injection, CD11b^+^ peritoneal macrophages were F4/80^hi^CD206^+^ ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). Eight weeks post-intraperitoneal injection with Thio, CD11b+ peritoneal macrophages were F4/80^hi^CD206^--^, similar to naïve untreated mice ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). We also examined the long-term fate of F480^int^CD206^+^PD-L2^+^ AAM^mono^ cells from Thio+IL-4c-treated CD45.1 mice following transfer into the peritoneal cavity of untreated CD45.2 recipient mice ([Fig. 1b](#F1){ref-type="fig"}). Eight weeks after transfer, less than 0.05% of total peritoneal cavity CD45.1^+^ cells were detected in the peritoneal cavity, yet they could be rapidly expanded over 4 days by injection of IL-4c in the recipient mice ([Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}). Following this IL-4c-driven expansion after 8 weeks, donor CD45.1^+^ macrophages were F4/80^hi^CD206^−^PD-L2^--^ ([Fig. 1b](#F1){ref-type="fig"}), suggesting that PD-L2 was not reinduced. Hence, following 8 weeks of residence in the peritoneal cavity, transferred AAM^mono^ had adopted a F4/80^hi^CD206^−^PD-L2^--^AAM^res^ phenotype.

We next examined how environmental changes altered the proliferative capacity of transferred macrophages as measured by 5-ethynyl-2′-deoxyuridine (EdU) incorporation 3 hours prior to harvest. More CD45.1^+^ donor cells were detected in mice transferred with F480^int^CD206^+^ macrophages from Thio+IL-4c-treated donors compared to recipients of F480^int^CD206^+^macrophages from Thio-treated donors ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}). However, 5 days post-transfer, both type of donor CD45.1^+^ macrophages had proliferated less than host CD45.2^+^AAM^res^ cells after 4 days of IL-4c treatment ([Fig. 1c](#F1){ref-type="fig"}). However, 8 weeks after transfer, donor CD45.1^+^macrophages from both Thio- and Thio+IL-4c-treated donors had incorporated EdU at similar levels as F480^hi^CD206^−^ host resident peritoneal macrophages ([Fig. 1d](#F1){ref-type="fig"}), indicating that after long-term residence in the peritoneal cavity transferred AAM^mono^ had adopted the proliferative capacity of AAM^res^ macrophages. As such, Ly6C^hi^ monocyte-derived F480^int^CD206^+^ macrophages can undergo conversion into tissue resident-like F480^hi^CD206^−^ macrophages.

The transcription factors STAT6 and IRF4 regulate expression of genes (e.g. *Retnla*) induced by IL-4 in macrophages^[@R14],\ [@R27]^. F480^int^CD206^+^ macrophages isolated from 4 days post Thio-treated CD45.2*Stat6^−/−^* mice and transferred into wild-type CD45.1 mice that were treated with IL-4c for 4 days did not upregulate PD-L2 ([Supplementary Fig. 2d](#SD1){ref-type="supplementary-material"}). Transferred *Stat6*^--/--^F4/80^int^CD206^+^ macrophages did not increase EdU incorporation more than control PBS treated mice in response to IL-4c treatment for 4 days ([Supplementary Fig. 2e](#SD1){ref-type="supplementary-material"}). However, they were F4/80^hi^CD206^−^ 8 weeks after transfer ([Fig. 1e](#F1){ref-type="fig"}), indicating that STAT6 is not required for the conversion to a tissue-resident phenotype, but may regulate proliferation. Similarly, transferred *Irf4*^--/--^F480^int^CD206^+^ macrophages adopted a tissue-resident F4/80^hi^CD206^−^ phenotype and did not induce PD-L2 expression in IL-4c-treated recipient mice 8 weeks post-transfer ([Fig. 1f](#F1){ref-type="fig"}), indicating that the conversion of Ly6C^hi^ monocyte-derived F480^int^CD206^+^ into tissue resident-like F480^hi^CD206^−^ macrophages is independent of both STAT6 and IRF4.

CX~3~CR1^+^ derived cells adopt a tissue-resident phenotype {#S3}
-----------------------------------------------------------

AAM^mono^ express CX~3~CR1^[@R19]^ and can be tracked in *Cx3cr1^CreERT2-IRES-EYFP^* mice (hereafter *Cx3cr1^Cre^*), which express a tamoxifen (TAM)-inducible Cre recombinase (CreERT2) under the control of the endogenous *Cx3cr1* promoter followed by an IRES-EYFP element^[@R28]^. To trace the fate of *Cx3cr1^Cre+^*cells without using adoptive transfers, we crossed *Cx3cr1*^CreERT2-EYFP/+^ mice with *Rosa26^stop-tdTomato^* reporter mice (hereafter R26^tdTomato^). We analyzed peritoneal macrophages in *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^ mice injected i.p. with Thio or Thio+IL-4c 1, 4 and 8weeks while simultaneously labeling *Cx3cr1^Cre+^* cells with a single dose of TAM, which irreversibly labels CX~3~CR1^+^ cells and their progeny by inducing expression of tdTomato. One week after Thio+IL-4c injection, peritoneal CD11b^+^tdTomato^+^ macrophages were 94.6% F4/80^int^CD206^+^, whereas 4 weeks after Thio+IL-4c injection 55.7% of CD11b^+^tdTomato^+^ macrophages were F4/80^hi^CD206^+^. Eight weeks post-treatment, 32.7% of CD11b^+^tdTomato^+^ cells had adopted a F4/80^hi^CD206^--^ tissue-resident phenotype ([Fig. 2a](#F2){ref-type="fig"}). CD11b^+^tdTomato^+^ macrophages can be induced to be PD-L2^+^ with 4 days of IL-4c treatment at 4 weeks, while those CD11b^+^tdTomato^+^ cells that have persisted in the peritoneal cavity at 8 weeks could no longer be induced to express PD-L2 by IL-4c treatment and expressed lower amounts of MHC class II ([Fig. 2b,c](#F2){ref-type="fig"}). Hereafter we refer to these converted tdTomato^+^F4/80^hi^CD206^--^ cells as AAM^conv^, to distinguish them from F4/80^hi^CD206^--^AAM^res^ that are tdTomato^−^.

RT-PCR analysis of AAM^conv^ cells sorted from the peritoneal cavity 8 weeks after Thio treatment, and treated with IL-4c for 4 days before harvest, indicated that in addition to losing the expression of CD206 and PD-L2, AAM^conv^ cells induced expression of UCP1, comparable to AAM^res^ in naïve mice ([Fig. 2d](#F2){ref-type="fig"}). As such, genetic fate-mapping experiments reproduced the results of the adoptive transfer and indicated that 8 weeks post an inflammatory response in the peritoneal cavity, recruited CX~3~CR1^+^ monocyte-derived cells had adopted a tissue-resident peritoneal macrophage phenotype.

AAM^conv^ acquire transcriptional and chromatin profiles of AAM^res^ {#S4}
--------------------------------------------------------------------

To further examine whether monocyte-derived inflammatory macrophages were truly re-programmed towards homeostatic, tissue-resident macrophages, we did global transcriptional profiling using RNA-seq and mapped chromatin accessibility regions using ATAC-seq in tdTomato^+^F4/80^int^CD206^+^ (AAM^mono^) and tdTomato^--^ F4/80^hi^CD206^--^ (AAM^res^) cells isolated 4 days after Thio+IL-4c or IL-4c respectively, and tdTomato^+^F4/80^hi^CD206^--^ (AAM^conv^) cells isolated 4 days after IL-4c following Thio injection 10 weeks prior to IL-4c treatment, from *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^mice kept on a continuous TAM diet to label all CX~3~CR1^+^ monocyte-derived cells during the treatment period ([Fig. 3a](#F3){ref-type="fig"}).

RNA-seq showed that AAM^conv^ had a gene expression profile similar to AAM^res^ by pairwise Euclidean distance calculation ([Fig. 3b](#F3){ref-type="fig"}), principal component analysis (PCA) ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}), and Pearsons correlation analysis ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}), despite sharing tdTomato expression with AAM^mono^. Differential analysis identified 7939 genes that were differentially expressed between AAM^conv^ and AAM^mono^, of which 3973 genes were more highly expressed in AAM^conv^ ([Fig. 3c](#F3){ref-type="fig"}). Many of these genes were enriched for gene ontology (GO) annotations involving the cell cycle ([Fig. 3d](#F3){ref-type="fig"}), which may reflect the increased proliferative capacity of AAM^conv^. Of the 1730 genes differentially expressed between AAM^conv^ and AAM^res^, most (1055) genes were more highly expressed in AAM^res^ ([Fig. 3c](#F3){ref-type="fig"}), indicating that AAM^conv^ had acquired most, but not all of the transcriptional features of AAM^res^. In addition, the log fold changes of these differential genes between AAM^conv^ and AAM^res^ were of lesser magnitude than the log fold changes of differential genes between AAM^conv^ and AAM^mono^ ([Fig. 3c](#F3){ref-type="fig"}). Unsupervised clustering analysis of expressed genes across AAM^mono^, AAM^conv^ and AAM^res^ showed that most of the transcriptional profile in AAM^conv^ (11042 genes in k-means clusters C2 and C3) resembled that of AAM^res^ ([Fig. 3e](#F3){ref-type="fig"}). However, there remained a subset of genes (2632 genes in k-means cluster C4) expressed in AAM^res^ that were not acquired by AAM^conv^ ([Fig. 3e](#F3){ref-type="fig"}).

In parallel with the RNA-seq, we used ATAC-seq to identify regulatory elements that are transposase-accessible in the populations of macrophages analyzed. At a global level, the chromatin profiles of AAM^conv^ were more similar to AAM^res^ than AAM^mono^, as indicated by pairwise Euclidean distance calculation ([Fig. 3f](#F3){ref-type="fig"}), pairwise Pearson's correlation ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}) and PCA ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Despite the common lineage from CX~3~CR1^+^ cells, differential analysis comparing tdTomato^+^AAM^conv^ to tdTomato^+^AAM^mono^ revealed greater differences in chromatin profiles (6050 differential regulatory elements) than when AAM^conv^ were compared to tdTomato^−^AAM^res^ (350 differential REs), and the differences were of greater magnitude ([Fig. 3g](#F3){ref-type="fig"}). Specific gene analysis indicated that distinct regulatory elements at the *Pdcd1lg2* locus (encoding PD-L2) were only accessible in AAM^mono^ but not in AAM^conv^ ([Fig. 3h](#F3){ref-type="fig"}), consistent with the cell surface expression of PD-L2, while AAM^conv^ cells gained accessibility to the *Ucp1* locus, which was also accessible in AAM^res^ but not in the AAM^mono^ cells ([Fig. 3h](#F3){ref-type="fig"}). Notably, the *Gata6*locus was accessible in AAM^mono^ cells ([Fig. 3h](#F3){ref-type="fig"}) even in the absence of GATA6 expression ([Fig. 3g](#F3){ref-type="fig"}), which may indicate a role for functional plasticity. As such, the differences in regulatory element accessibility and chromatin landscapes correlated with the functionality of AAM^mono^, AAM^res^ and AAM^conv^ cells. Unsupervised clustering analysis of the accessible regulatory elements in AAM^mono^, AAM^res^ and AAM^conv^ assigned the regulatory elements to three different clusters, of which C1 (14075 regulatory elements) contained largely AAM^mono^-specific regulatory elements, while C3 contained 13280 regulatory elements that were common to both AAM^conv^ and AAM^res^([Fig. 3i](#F3){ref-type="fig"}), similar to the findings of the supervised differential analyses. Hence, AAM^conv^ have transcriptional and chromatin profiles more similar to AAM^res^, than AAM^mono^ despite being derived from the same CX~3~CR1^+^ lineage as AAM^mono^.

Vit-A-deficient mice have defective generation of AAM^res^ cells {#S5}
----------------------------------------------------------------

Because retinoic acid can induce GATA6 dependent peritoneal macrophage differentiation^[@R25]^, we generated vitamin A-deficient C57BL/6 wild-type mice that were maintained on a vitamin A deficient diet beginning at day 10 of gestation (Vit-A^DEF^), in comparison to wild-type mice maintained on a control diet (Vit-A^CON^). Vit-A^DEF^ mice at 8 weeks lacked F4/80^hi^CD206^--^ resident peritoneal macrophages ([Fig. 4a](#F4){ref-type="fig"}), consistent with previous reports^[@R25]^. While the total number of peritoneal cells at steady-state were lower in Vit-A^DEF^ compared to Vit-A^CON^ ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}), the total number and % of F4/80^int^CD206^+^ macrophages ([Fig. 4a](#F4){ref-type="fig"} and [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}) was increased compared to controls. FSC^lo^SSC^hi^ granulocytes were also increased compared to Vit-A^CON^ (data not shown), as previously described^[@R29]^. Intraperitoneal injection of IL-4c in Vit-A^DEF^ mice induced the expansion of F4/80^int^PD-L2^+^AAM^mono^ cells, compared to the expansion of F4/80^hi^PD-L2^--^AAM^res^ cells in Vit-A^CON^ ([Fig. 4b](#F4){ref-type="fig"}). The proliferation of peritoneal CD11b^+^F4/80^+^ macrophages following IL-4c treatment, as determined by incorporation of EdU, was also significantly reduced in Vit-A^DEF^ mice compared to Vit-A^CON^ mice ([Fig. 4c](#F4){ref-type="fig"}), suggesting that inflammatory F4/80^int^CD206^+^ macrophages accumulate in Vit-A^DEF^ mice. Vit-A^DEF^ mice that were treated with all-trans retinoic acid every 2 days for 14 days prior to IL-4c treatment have 33% F4/80^hi^PD-L2^−^AAM^res^ cells compared to 0.3% in DMSO control treated Vit-A^DEF^ mice, but 50% of the CD11b+ macrophages have a CD206^+^F4/80^hi^PD-L2^+^ intermediate phenotype ([Fig. 4d](#F4){ref-type="fig"}). These results indicate that vitamin A and retinoic acid may regulate the balance between inflammatory and tissue resident macrophages in the peritoneal cavity.

Vit-A deficiency disrupts AAM^mono^ to AAM^res^ conversion {#S6}
----------------------------------------------------------

We next tested if vitamin A deficiency impacts the long-term conversion of monocyte-derived F4/80^int^CD206^+^ macrophages into F4/80^hi^CD206^−^ tissue resident macrophages. F4/80^int^CD206^+^ macrophages from CD45.1 mice treated with Thio were transferred into CD45.2 Vit-A^DEF^ or Vit-A^CON^ mice, which received IL-4c i.p. injections 8 weeks post-transfer ([Fig. 5a](#F5){ref-type="fig"}). The number of CD45.1^+^ macrophages recovered from Vit-A^DEF^ recipients 4 days after IL-4c treatment was reduced 2 fold compared to Vit-A^CON^ recipient mice ([Fig. 5a](#F5){ref-type="fig"}). CD45.1 mice treated directly with IL-4c without adoptive transfer were used as FACS gating and staining controls. At 8 weeks post-transfer into CD45.2 Vit-A^CON^ mice, donor CD45.1^+^F4/80^+^ macrophages were 91.5% PD-L2^−^CD206^−^ ([Fig. 5b--d](#F5){ref-type="fig"}), indicating conversion into tissue resident macrophages. In contrast, 73.6% of donor CD45.1^+^F4/80^+^ macrophages transferred into Vit-A^DEF^ mice were PD-L2^+^CD206^+^ ([Fig. 5b--d](#F5){ref-type="fig"}) and had lower expression of F4/80 and higher expression of MHCII than donor macrophages in Vit-A^CON^ mice, which were PD-L2^−^CD206^−^ ([Fig. 5c,d](#F5){ref-type="fig"}), indicating that a vitamin A deficient environment disrupts inflammatory macrophages conversion into a tissue-resident phenotype.

We also tested the requirement for vitamin A in inflammatory to resident-macrophage conversion in *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^ mice maintained on a vitamin A-deficient diet beginning at day 10 of gestation prior to TAM treatment and i.p. injection with Thio, followed by IL-4c injection eight weeks later. 4 days after IL-4c treatment 51.5% of tdTomato^+^ macrophages were F4/80^hi^CD206^--^PD-L2^−^ in *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^ Vit-A^CON^ mice, compared to 0% in *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^ Vit-A^DEF^ mice ([Fig 5e,f](#F5){ref-type="fig"}), indicating impaired conversion. Next we tested whether the accumulation of inflammatory macrophages in the Vit-A^DEF^ mice was reversible. In *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^ Vit-A^DEF^ mice switched back to control diet, 60% of tdTomato^+^ cells were F4/80^hi^CD206^--^ after 8 weeks on a control diet ([Fig. 5e,f](#F5){ref-type="fig"}). RT-PCR analysis of tdTomato^+^ macrophages sorted from Vit-A^DEF^ and Vit-A^CON^ *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^mice from these experiments indicated that *Ucp1*and *Gata6* mRNA were only expressed in tdTomato^+^ AAM^conv^ from Vit-A^CON^ mice ([Fig. 5g](#F5){ref-type="fig"}). However, *Ucp1* and *Gata6* mRNA expression was restored in tdTomato^+^ cells from Vit-A^DEF^ mice 8 weeks after switch back to control diet ([Fig. 5g](#F5){ref-type="fig"}). Thus, vitamin A sufficiency was required for the conversion of F4/80^int^CD206^+^ into F4/80^hi^CD206^--^ macrophages in both an adoptive transfer model and the *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^mice.

Macrophages in *S. mansoni* granulomas are heterogenous {#S7}
-------------------------------------------------------

*Arg1*^+^*Retnla*^+^*Chi3l3*^+^PD-L2^+^ AAM in early liver granulomas of *S. mansoni*-infected mice are derived from inflammatory Ly6C^hi^ monocytes^[@R15],\ [@R16]^. We next tested if macrophages convert to a AAM^res^ phenotype as the granulomas mature in C57BL/6 mice infected with *S. mansoni*. *S. mansoni* eggs begin to be lodged in the liver between 5--6 weeks post infection. While we detected considerable heterogeneity between individual mice, *Ucp1* mRNA expression was detectable in the liver by RT-PCR at 8 weeks post *S. mansoni*-infection ([Fig. 6a](#F6){ref-type="fig"}), whereas it was undetectable in the liver of uninfected mice. Time course analysis indicated that *Ucp1* was only detectable between 7--8 weeks post infection ([Fig. 6b](#F6){ref-type="fig"}) indicating that at least 7 days post-egg deposition are required prior to mRNA expression of *Ucp1* in the liver.

Granuloma macrophages show no significant increase in proliferation at 8 weeks post infection^[@R15],\ [@R16]^. However, at 12 and 15 weeks post-infection more EdU^+^F4/80+ macrophages were detected in the livers of *S. mansoni* infected mice compared to uninfected mice ([Fig. 6c,d](#F6){ref-type="fig"}), although expression of *Ucp1* was not significantly greater at 12 weeks compared to 9 weeks post-infection ([Supplementary Fig. 5a](#SD1){ref-type="supplementary-material"}). We used a 3-hour pulse-labeling and EdU staining on tissue sections to determine if the pattern of UCP1 expression was associated with cells that have incorporated EdU in the liver granulomas at 8 weeks post-infection. UCP1 staining was not detected in small and immature granulomas (\<200μm) and was observed predominantly at the periphery of histologically more mature and organized granulomas (\>200μm) ([Fig. 6e](#F6){ref-type="fig"} and [Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}). Whereas EdU^+^ cells were detected throughout the immature granuloma ([Fig. 6f](#F6){ref-type="fig"}), EdU^+^ cells were only found in the periphery of the mature granulomas, where UCP1^+^ cells were also detected ([Fig. 6e,f](#F6){ref-type="fig"} and [Supplementary Fig. 5b,c](#SD1){ref-type="supplementary-material"}), indicating that the distribution of proliferating cells was distinct as the granulomas matured and that there was partial overlap between proliferation and UCP1 expression.

To observe the clonal expansion of CX~3~CR1^+^ monocyte derived cells, we crossed the *Cx3cr1^CreERT2-IRES-EYFP^* mice to the *Rosa26^Brainbow2.1^*reporter mice^[@R30]^, which stochastically express one of four fluorescent proteins (GFP, YFP, RFP and CFP) when Cre expression is induced by TAM in CX~3~CR1^+^ cells to recombine the \"Confetti\" gene. In this system, proliferation of any CX~3~CR1^+^ cell produces progeny expressing the same fluorescent protein as the original cell, allowing tracing of proliferating clones, which appear as patches^[@R30]^. *Cx3cr1^CreERT2-EYFP^*^/+^*Rosa26^Brainbow2.1^*^/+^ mice were infected with *S. mansoni* and pulsed with TAM at either 7 or 11 weeks post-infection. At 12 weeks post-*S. mansoni* infection (i.e. 5 weeks or 1 week post-TAM) small and immature granulomas showed even distribution of different fluorescent dye-labeled cells in close proximity to the eggs ([Fig. 6g](#F6){ref-type="fig"}), indicating that these cells had independently recombined the \"Confetti\" gene and were not derived from a single clone. In contrast, in mature granuloma, patches of cells expressing the same fluorescent dye were only found in the periphery of the granulomas ([Fig. 6e,f](#F6){ref-type="fig"}), indicating the clonal expansion of CX~3~CR1^+^ cells, and consistent with the detection of EdU^+^ cells in the periphery of mature granulomas. These results suggest that AAM^mono^ cells undergo proliferation and may convert to the AAM^conv^ phenotype as granulomas become more organized and mature.

Tracking CX~3~CR1^+^cells in the liver of *S. mansoni* infected mice {#S8}
--------------------------------------------------------------------

Next, we monitored the fate of CX~3~CR^+^ monocyte derived cells in *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^mice infected with *S. mansoni* and treated with TAM at 5 weeks post-infection. At 1 week post-TAM, corresponding to 6 weeks post-infection, more than 50% of CD11b^+^ cells in the liver were tdTomato^+^, while at 5 weeks post-TAM, corresponding to 10 weeks post-infection, \<1% of CD11b^+^ cells in the liver were tdTomato^+^ ([Fig. 7a,b](#F7){ref-type="fig"}), indicating that CX~3~CR1^+^ monocyte-derived cells have a rapid turnover during infection. Notably, 34.8% of the CD11b^+^F4/80^+^ cells were YFP^−^ at 1week post-TAM ([Fig. 7c](#F7){ref-type="fig"}), indicating they had already downregulated CX~3~CR1 expression. Next we analyzed the cell surface phenotype of *Cx3cr1*-YFP^+^tdTomato^−^, YFP^+^tdTomato^+^, YFP^−^tdTomato^+^ and YFP^−^tdTomato^−^ cells. PD-L2^+^CD206^+^AAM^mono^ cells were observed in the YFP^+^tdTomato^+^ (8.7%) and YFP^+^tdTomato^--^ (6.9%) compartment, compared to YFP^--^tdTomato^+^ (0.45%) cells ([Fig. 7d,e](#F7){ref-type="fig"}). RT-PCR analysis of sorted cells showed that *Ucp1* was expressed in the tdTomato^+^ compartment ([Fig. 7f](#F7){ref-type="fig"}). These results indicate that macrophages derived from CX~3~CR1^+^ precursors can adopt different phenotypes during *S. mansoni* infection, and can adopt a phenotype similar to AAM^conv^ as they downregulate CX~3~CR1.

Given the rapid turnover of tdTomato^+^ cells in the liver during *S. mansoni* infection, we maintained *S. mansoni*-infected *Cx3cr1*^CreERT2-EYFP/+^ R26^tdTomato/+^ mice on a TAM-containing diet to allow continuous labeling of CX~3~CR1^+^ cells. At 12 weeks post infection (6 weeks on TAM diet) we found an increase in tdTomato^+^YFP^−^ cells in the liver compared to 8 weeks post infection (2 weeks on TAM diet) ([Fig. 7g](#F7){ref-type="fig"}). PD-L2, CD206 and MHCII expression was detected by FACS on YFP^+^ cells, but not on tdTomato^+^YFP^--^ cells ([Fig. 7h](#F7){ref-type="fig"}), while *Ucp1* transcripts were detected by RT-PCR in sorted tdTomato^+^ cells ([Fig. 7f](#F7){ref-type="fig"}), consistent with studies indicating that CX~3~CR1^+^ monocyte-derived cells can adopt a tissue-resident macrophage phenotype in the liver^[@R7]^.

When we infected Vit-A^DEF^ C57BL/6 mice with *S. mansoni*, we observed \>80% mortality over 10 weeks compared to no mortality in *S. mansoni*-infected Vit-A^CON^ mice ([Fig. 8a](#F8){ref-type="fig"}). Expression of *Ucp1* mRNA was significantly reduced in the livers of *S. mansoni*-infected Vit-A^DEF^ mice compared to Vit-A^CON^ mice 8 weeks post infection ([Fig. 8b](#F8){ref-type="fig"}), and the organization of UCP1^+^ cells in the periphery of liver granulomas was disrupted ([Fig. 8c](#F8){ref-type="fig"}). Furthermore, there was reduced incorporation of EdU and *Gata6* mRNA expression in CD11b^+^F4/80^+^ macrophages in the livers of *S. mansoni*-infected Vit-A^DEF^ mice compared to infected Vit-A^CON^ mice ([Fig. 8b, c](#F8){ref-type="fig"}). Treatment of *S. mansoni*-infected Vit-A^DEF^ mice with ATRA induced the recovery of F4/80^hi^ macrophages ([Fig. 8d,e](#F8){ref-type="fig"}) and *Ucp1* and *Gata6* mRNA expression were increased in the liver ([Fig. 8b,c](#F8){ref-type="fig"}) compared to untreated Vit-A^DEF^ mice, while UCP1and EdU stain were restored in the periphery of mature liver granulomas ([Fig. 8c](#F8){ref-type="fig"}). We also observed fewer SiglecF^+^ eosinophils in the livers of *S. mansoni*-infected Vit-A^DEF^ mice compared to mice on a control diet, which was partially restored by ATRA ([Fig. 8f](#F8){ref-type="fig"}), suggesting restoration of the type 2 immune response, which was disrupted during vitamin A deficiency. Thus, retinoic acid may restore both type 2 responses and macrophage conversion.

We also examined conversion of CX~3~CR1^+^ monocyte-derived cells into macrophages during lung granuloma formation 7 days after *S. mansoni* eggs were delivered *i.v.* (after *i.p.* sensitization with *S. mansoni* eggs for 14 days) in Vit-A^DEF^ *Cx3cr1CreERT2-EYFP*/+:*R26R-tdTomato*/+ mice ([Supplementary Fig. S6a](#SD1){ref-type="supplementary-material"}). There was no significant difference in the accumulation of tdTomato^+^ cells in the lung compared to Vit-A^CON^ mice ([Supplementary Fig. S6a](#SD1){ref-type="supplementary-material"}). Almost no CD11b^+^tdTomato^+^ cells have downregulated CX3CR1-YFP, unlike in liver granulomas. We also examined macrophages in lung granulomas in wild-type (CD45.1):*Stat6^−/−^* (CD45.2) mixed (50:50) bone marrow chimeras injected *i.v.* with *S. mansoni* eggs. *Stat6^−/−^* and wild-type CD11b^+^F4/80^+^ macrophages in lung granulomas maintained an equal ratio and did not show significant differences in marker phenotype or proliferative capacity indicating a limited role for IL-4 and IL-13 in expanding macrophage numbers ([Supplementary Fig. S6b](#SD1){ref-type="supplementary-material"}). The wild-type: *Stat6−/−* mixed bone marrow chimeras were infected physiologically with *S. mansoni* cercariae and they all rapidly lost weight and died at 7 weeks post infection ([Supplementary Fig. S6c](#SD1){ref-type="supplementary-material"}). Hence, STAT6 may play a more dominant role in the function of liver granuloma macrophages during natural infection compared to lung granulomas from *i.v.* delivered eggs.

Discussion {#S9}
==========

Macrophages are highly plastic cells that respond to the environment to adopt tissue specific phenotypes, regardless of their embryonic or adult bone marrow origin^[@R31]^. Here, we show that monocyte-derived F480^int^CD206^+^MHCII^+^ inflammatory macrophages can convert into a tissue resident F4/80^hi^CD206^−^ MHCII^−^ phenotype after residence in the tissues, and that this process is dependent on vitamin A. We previously reported that UCP1 was only expressed by F4/80^high^CD206^--^ AAM^res^ in naïve mice treated with IL-4c and was a marker for AAM^res^ cells^[@R19]^, but here we find that AAM^conv^ cells also gain expression of UCP1. While chromatin accessibility is often considered to be a mark of cellular lineage, here we find that both the changes to transcriptional profiles and cell surface phenotype of the AAM^conv^ were accompanied by near complete remodeling of the chromatin landscape to closely resemble AAM^res^, and that the changes to chromatin accessibility correlated with expression of the markers PD-L2 and UCP1. In Vit-A^DEF^ mice infected with *S. mansoni*, failure to convert from monocyte-derived inflammatory macrophages into a tissue resident phenotype is associated with disrupted liver granuloma architecture and increased mortality.

Retinoic acid can induce the expression of the transcription factor *Gata6*^[@R25]^, which regulates the differentiation of resident peritoneal macrophages^[@R25],\ [@R32],\ [@R33]^. GATA6^+^ macrophages accumulate in the liver following sterile injury^[@R34]^. While we have not specifically tested the role of *Gata6* in the differentiation of AAM^mono^ into the AAM^res^ phenotype, expression of *Gata6* in the liver was induced during *S. mansoni* infection and reduced in Vit-A^DEF^ mice.

Notably, we found reduced numbers of CD11b+MHCII+ macrophages in the lungs and the gut of uninfected Vit-A^DEF^ mice compared to mice on a control diet, in contrast to expanded numbers in the peritoneal cavity. This indicates that there are environmental changes in different tissues during vitamin A deficiency that have different effects on tissue macrophages. Whether retinoic acid and vitamin A play an equally important role in macrophage conversion during inflammation in other tissues remains to be established. Whereas we observed that liver granulomas during *S. mansoni* infection clearly required vitamin A for macrophage conversion, this was not the case for lung granulomas when *S. mansoni* eggs were delivered *i.v.* The shorter time frame of the more acute lung granuloma model may account for these differences and indeed few CD11b^+^tdTomato^+^ cells have downregulated CX3CR1-YFP after just 7 days. Alternatively, tissue specific requirements of inflammatory lung macrophages for vitamin A may be different from the liver and peritoneal cavity.

Vitamin A deficiency is associated with increased mortality of children in developing countries and it has been called an "anti-infective" vitamin^[@R23]^. Because of the pleiotropic effects of retinoic acid and vitamin A-deficiency, it is difficult to definitively conclude that the increased morbidity observed in *S. mansoni*-infected Vit-A^DEF^ mice was due specifically to the alterations in macrophage conversion and not to an underlying state of inflammation in these mice. While granuloma formation in Vit-A^DEF^ mice was restored by treatment with retinoic acid, this could also be due to the restoration of the type 2 immune responses. Type 2 responses are disrupted during vitamin A deficiency and are critical for the proper formation of *S. mansoni* egg granulomas^[@R10]^.

Our current observations show that monocyte-derived macrophages can eventually adopt phenotype similar to that of tissue-resident macrophages of embryonic lineage after long-term residency in the tissue. This is consistent with reports showing that embryonic-derived tissue-resident macrophages can be replaced by bone marrow--derived macrophages that adopt the phenotypic and functional features of the original, embryonically-derived population^[@R7],\ [@R8],\ [@R36]^. This process is likely accelerated by inflammation, as demonstrated following γ-irradiation and bone marrow transplantation^[@R35]^. But even under steady-state conditions, in the absence of inflammation, adult bone marrow-derived hematopoiesis can replace a proportion of the embryonically-derived, tissue-resident macrophages during normal aging^[@R7],\ [@R8],\ [@R22]^. Hence, the underlying ontogeny of the cells may not contribute significantly towards differences in their functional properties.

Here we show a role for vitamin A for an appropriate conversion of inflammatory macrophages to a tissue-resident phenotype in the peritoneal cavity and the liver during type 2 responses. Retinoic acid-dependent phenotypic conversion of macrophages may be a physiologically important regulatory process during chronic inflammatory responses, as vitamin A deficiency is associated with increased morbidity and mortality to various infections in the developing world. An accumulation of inflammatory macrophages and the failure to resolve inflammation may have detrimental consequences in conditions of vitamin A deficiency.

Online Methods {#S10}
==============

Mice {#S11}
----

C57BL6/J (CD45.2), B6.SJL (CD45.1), *Rosa26^Brainbow2.1/Brainbow2.1^*, *Rosa26^floxed-tdTomato/floxed-TdTomato^*, and C57BL6/J Stat6^−/−^ mice were purchased from Jackson laboratories (Bar Harbor, ME) and bred in a specific pathogen free (SPF) facility. *Cx3cr1^CreERT2-IRESYFP/CreERT2-IRESYFP^*mice were generously provided by Dr. Wenbiao Gan and Dr. Dan Littman (Skirball Institute, New York University Medical Center). Mice for Vitamin A deficiency experiments were generated as described previously^[@R37]^. Briefly, pregnant dams were fed a Vitamin A deficient (0 IU/g, TD.86143 Harlan Teklad) or control (20,000 IU/g, TD.93160) diet starting at day 10 of gestation and continuing through weaning. After weaning, mice were maintained on the same diet for the duration of the experiment. Serum retinol levels in the VAD mice on this protocol were reduced to \~0.35 μM, a level defined by the World Health Organization as severe Vitamin A deficiency. All studies were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals. All animal procedures were approved by the NYU Institutional Animal Care and Use Committee under protocol number 131004 and 130504.

Models of helminth infection and peritoneal inflammation {#S12}
--------------------------------------------------------

Mice were infected percutaneously with 50 *Schistosoma mansoni* cercariae (Puerto Rican strain NMRI; Biomedical Research Institute) and analysis of liver leukocytes was performed after 7.5--15 weeks post-infection. For peritoneal inflammation, mice treated with IL-4/anti-IL-4 Ab complexes (IL-4c) prepared as described previously^[@R17],\ [@R18]^. IL-4c were given i.p on days 0 and 2. Mice were also treated with 4% thioglycollate on day 0 alone or in combination with IL-4c as indicated. Mice were sacrificed on day 4, unless otherwise noted for time course experiments. Tamoxifen (Sigma) was dissolved in corn oil and given by oral gavage at a dose of 500mg/kg body weight. For continuous labeling experiments, *Cx3cr1^CreERT2-IRESYFP/+^ Rosa26^floxed-tdTomato/+^* were switched onto a chemically defined Tamoxifen diet (Envigo, TD.130855) at the indicated time during infection for the remainder of the experiment.

S. mansoni egg injection model {#S13}
------------------------------

*S. mansoni* eggs were isolated from infected mouse livers and injected into mice as previously described^[@R38]^. Briefly, *S. mansoni* eggs were then injected (5000eggs/mouse) into the peritoneal cavity and the mice were rested for 14 days. Fresh *S. mansoni* eggs were then isolated and injected retro-orbitally and mice were rested for 8 days upon which PECs and lungs were isolated for flow cytometry analysis.

Lung macrophage isolation {#S14}
-------------------------

Isolated mouse lungs were minced dry and digested (0.25mg/mL Liberase TM, 60mg BSA, 150Kunitz DNase I) at 37°C for 45min. Digested tissue was then passed through a 100um strainer and subsequently through a 50um strainer. Cell suspensions were stained with fluorescently-tagged antibodies and analyzed on via flow cytometry as described below.

*In Vivo* retinoic acid (RA) Reconstitution and diet switching {#S15}
--------------------------------------------------------------

A total of 250μg of all-trans-retinoic acid (ATRA) (Sigma Aldrich) in 30 μl of biotechnology performance certified DMSO (Sigma Aldrich) was administered intraperitoneally to VAD mice every other day for 14 days. Mice not receiving RA received DMSO vehicle. For diet switching experiments Vitamin A deficient mice Vit-A^DEF^ generated as described previously were treated with thioglycollate at 8 weeks of age and allowed to rest for 24hrs. They were then gavaged with 500mg/kg of tamoxifen and their diet switched to a Vitamin A control containing 20,000 IU of Vitamin A for the remainder of the experiment.

Tissue preparation and peritoneal cell isolation {#S16}
------------------------------------------------

Liver tissues were processed as described previously^[@R39]^. Briefly livers were chopped and incubated in collagenase VIII (100U/ml; Sigma) and DNase I (150 μg/ml; Sigma) for 45 minutes at 37°C and then passed through a 100 μm cell strainer (BD Biosciences). Leukocytes were enriched by density gradient centrifugation over a 40/80% Percoll (GE Healthcare) gradient and remaining RBCs were lysed with ACK lysis buffer, washed in complete media and used for analysis. Peritoneal cells were isolated by washing the peritoneal cavity with 10 ml of cold 1× PBS (HyClone). Peritoneal exudate cells were treated with ACK lysis buffer (Lonza, Walkersville) to lyse red blood cells and washed with cold 1× PBS. Cells were either used immediately for further staining and analysis by flow cytometry or lysed with TRIzol for RNA extraction.

Flow cytometry and cell sorting {#S17}
-------------------------------

Single cell suspensions were stained with fluorescently conjugated antibodies in a 1:100 dilution unless otherwise noted. Cells were stained with LIVE/DEAD™ Aqua or Blue (Invitrogen), blocked with 4μg/ml anti-CD16/32 (2.4G2; Bioxcell) and the stained with anti-CD11b eFluor450 (M1/70; Biolegend), anti-CD11b BV650 (M1/70; Biolegend), anti-CD11b AF700 (M1/70; Biolegend) anti-MHCII APC-Cy7 (M5/114.15.2; Biolegend), CD45.1 FITC (A20; Biolegend), CD45.1 PerCP/Cy5.5 (A20; Biolegend), CD45.2 FITC (104; Biolegend), CD45.2 PerCP/Cy5.5 (104; Biolegend), F4/80 PECy7 (BM8; Biolegend), CD206 APC (C068C2; Biolegend), Siglec-F BV421 (E50-2440; BD Biosciences), Siglec-F PE (E50-2440; BD Biosciences), PD-L2 PE (TY25; Biolegend), PD-L2 PerCP-Vio700 (MIH-37; Miltenyi Biotec) CD3 PE (17A2; Biolegend), CD19 PE (6D5; Biolegend), CD49b PE (DX5; Biolegend). For EdU labeling, mice were pulsed with 0.5 mg of EdU for 3h prior to sacrifice and single cell suspensions were surface stained, fixed in 2% PFA for 10 min at RT, permeabilized, and stained for EdU (Invitrogen) per the manufacturer's instructions. Samples were analyzed on an LSRII and sorted on an Aria II cell sorter (BD Biosciences). For FACS-purifying peritoneal macrophages, cells were gated on singlet, live, Dump-negative (CD3^−^, CD19^−^, DX5^−^, Siglec-F^−^) CD11b^+^ then subsequently gated on their AAM^res^ (F4/80^hi^, CD206^−^, tdTomato^−^), AAM^mono^ (F4/80^int^, CD206^+^, tdTomato^+^) or AAM^conv^ (F4/80^hi^, CD206^−^, tdTomato^+^) phenotype.

RNA isolation for RNA-Seq {#S18}
-------------------------

RNA isolation from FACS-purified macrophages was done using the QIAgen Rneasy Micro Kit and QIAgen Rneasy Micro Kit where cell number was less than 5×10^5^ cells. RNA-Seq library preparation was done at the NYU School of Medicine Genome Technology Core using a low-input protocol with the TotalScript RNA-Seq kit (Epicentre). Libraries were sequenced on the HiSeq 2000 (Illumina) with 2 × 50 cycles and for an average of 50 million reads per sample.

Assay for Transposase-Accessible Chromatin with Sequencing (ATAC-Seq) {#S19}
---------------------------------------------------------------------

Assay for Transposase-Accessible Chromatin with Sequencing (ATAC-Seq) was performed as described by Buenrostro et al^[@R40]^. 50,000 FACS-purified cells per sample were spun down at 1500rpm for 5 min at 4°C and washed once with 50μl cold PBS. Cells were lysed with 50μl lysis buffer (10 mM Tris-HCl, pH7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630) and immediately spun down at 1500rpm for 10 min at 4°C. The isolated cell nuclei were then incubated for 30 min at 37°C with 50μl of transposase reaction, which contained 25μl Tagment DNA buffer (Illumina), 2.5μl Tagment DNA enzyme (Illumina) and 22.5μl nuclease-free water. The transposed DNA was immediately purified using the Qiagen MinElute PCR Purification Kit (Qiagen) following manufacturer\'s guide and eluted at 10ul volume. PCR amplification of the transposed DNA was done using a low-cycle number protocol and with primers published by Buenrostro et al^[@R40]^. Each PCR mix contained of 25μl of NEB 2× PCR Mix (New England Biolabs), 2.5μl of 25μM forward primer (Primer Ad1_noMX), 2.5μl of 25μM reverse barcoded primer, 0.3μl of 100× SYBR Green (Invitrogen) and 10μl of transposed DNA. PCR was carried out with the cycling protocol: 72°C for 5 min, 98°C for 30s, followed by 5 cycles of 98°C for 10s, 63°C for 30s, 72°C for 1 min. The reaction was held at 4°C after the 5^th^ cycle. A side qPCR was set up using the PCR product from these 5 cycles of amplification. Each qPCR mix contained 5μl NEB 2× PCR Mix, 0.25μl 25μM forward primer, 0.25μl 25μM reverse barcoded primer, 0.06μl 100× SYBR Green, 4.44μl nuclease-free water and 5μl of the PCR-amplified product. qPCR was carried out using the cycling protocol: 98°C for 30s, followed by 25 cycles of 98°C for 10s, 63°C for 30s, 72°C for 1 min and plate read. The qPCR amplification plot was then used to calculate the additional number of cycles needed for the PCR to achieve maximum amount of product without going into saturation. Each sample was amplified for a total of 13--15 cycles. The amplified libraries were then purified using Qiagen MinElute PCR Purification kit following manufacturer's guide and eluted at 20μl volume. Libraries were sequenced on the HiSeq 2000 with 2 × 50 cycles and for an average of 50 million paired-end reads per sample.

RNA-Seq primary data processing {#S20}
-------------------------------

Raw RNA-Seq reads were aligned to the reference mouse genome Grcm38 and the Ensembl reference transcriptome Grcm38.84.gtf using Tophat (version 2.1.0) with all parameters kept at default settings^[@R41]^. Reads with mapping quality score (MAPQ) less than 30, as well as reads mapping to mitochondrial DNA and chromosome Y, were removed. The median number of filtered reads per sample was 40,230,370. The number of filtered reads were subsequently counted for each gene using htseq-count, with the parameters --mode=union and --stranded=no^[@R42]^. The resulting count matrix was used for downstream analyses.

ATAC-Seq primary data processing {#S21}
--------------------------------

Raw ATAC-Seq reads were aligned to the reference mouse genome mm10 using bowtie2 (v2.2.9), with the parameters --maxin 2000 and --local, while keeping all other parameters at default settings^[@R43]^. To keep only highly unique alignments, reads with MAPQ score less than 30 were removed. We further removed all duplicate reads, as well as reads mapping to mitochondrial DNA and chromosome Y. After all filtering steps, reads were merged across all replicates from the same macrophage population. This resulted in a median depth of 44,724,457 reads per macrophage population. To identify accessible chromatin regions, we performed peak calling with the PeaKDeck (v1.1) algorithm, which measures signal density from randomly sampled bins genome-wide before generating a data set-specific probability distribution to identify regions with significant signal enrichment^[@R44]^. We ran PeaKDeck using sampling bins that consist of a 75bp central bin (-bin) and a 10000bp background bin (-back). Sampling along the genome was done in steps (-STEP) of 25bp and the background probability distribution was generated using 100000 randomly selected sites (-npBack). Significance was defined using a p-value of less than 0.00001 and regions with significant p-values were defined as a "peak" (i.e. an accessible chromatin region). We next counted the number of reads present at each accessible region in order to analyze the ATAC-Seq data using quantitative approaches. To do this, we first generated a set of consensus peaks across the data set by taking the union of peaks called from each macrophage population. Peaks were merged if overlapping by 1bp or more. The number of reads at each peak within the union peak sets were then counted for each sample. Finally, each peak was re-centered +/-100bp on its summit, defined as the position with maximum pile up of reads. Re-centering on peak summits was performed as this should coincide with the binding event of a transcription factor within an accessible chromatin region. We implemented the read counting and peak summit re-centering steps directly using the dba.count function from the Bioconductor package DiffBind (version 1.14.2)^[@R45]^. The final count matrix, which consisted of 34462 peaks, was used for downstream analyses.

RNA-Seq and ATAC-Seq data analyses {#S22}
----------------------------------

Regularized logarithmic (rlog) transformation was performed on count data matrices generated from RNA-Seq and ATAC-Seq as described above^[@R46]^. For RNA-Seq data, the maximum rlog count value for each gene across the data set was determined and only genes which had a maximum value greater than the 25^th^ percentile of per-gene maximum values were kept for between-sample comparisons and clustering analyses. This resulted in 17421 genes. For ATAC-Seq data, we kept count data for all 34662 peaks.

Pairwise, between-sample Euclidean distance and Pearson's correlation were calculated for the transcriptional and accessible chromatin profiles, respectively, to quantitate the similarities between samples. Clustering analysis was performed using the Clustering Large Application (CLARA) algorithm. CLARA is a more robust version of k-means and is implemented in a computationally efficient way suitable for clustering large data set^[@R47]^. We used the maximum average silhouette width to select for optimal number of clusters (K=5 for RNA-Seq data and K=3 for ATAC-Seq data).

Supervised differential analyses based on the negative binomial distribution with moderated dispersion value estimation were performed using the workflow directly implemented through the Bioconductor package DESeq2 (version 1.10.1) for both RNA-Seq and ATAC-Seq count data^[@R46]^. Tissue converted macrophages were compared to its reference monocyte-derived macrophages and tissue resident macrophages in two different contrasts. Differential genes and regulatory elements were defined using a False Discovery Rate (FDR) of 10% and \|log2 fold change\| greater than zero. Gene ontology (GO) enrichment analysis was done for genes with differential expression in both contrasts using GOstats^[@R48]^. Genes for each GO term (from the ontology "Biological Processes") were treated as an independent gene set and enrichment within the differential gene list was determined using the standard hypergeometric test, with a p-value cut off of 0.0001 and a background set containing all annotated genes within the mm10 reference genome^[@R48]^. All analyses done on processed RNA-Seq and ATAC-Seq reads were done in R (version 3.2.3). The raw and processed sequencing data was deposited into PubMed as a SuperSeries (GSE95003).

Macrophage transfers {#S23}
--------------------

Inflammatory macrophages harvested from donor mice induced with thioglycollate, IL-4c, or Thio + IL-4c were elicited as described above in congenic CD45.1 or CD45.2 mice on C57BL/6 background. PECs were harvested, stained with LIVE/DEAD viability, lineage (CD3, B220, DX5, Siglec F), CD11b and F4/80 and sorted. Cells were sorted by collecting single, live, lineage (CD3, B220, DX5, Siglec F) negative, CD11b^+^, F4/80^+^ cells and were sorted directly into FBS using a 100 μm nozzle on BD FACS Aria II. Cells were washed twice, counted and re-suspended in cold 1× PBS. Recipient mice, including WT CD45.2 mice, or mice on either CON or VAD diets (as indicated) received between 2.5--5.0×10^5^ to 1.8×10^6^ donor macrophages by i.p. injection. Recipients that received donor macrophages were then rested for either 24 hours for short term transfers or 8 weeks for long term transfers before being treated with 2 doses of IL-4c as described above and analyzed on day 4 after IL-4c treatment began. Mice were pulsed with EdU and PECs (including both donor and recipient cells) were harvested and stained as described above for LIVE/DEAD, CD45.1, CD45.2, PDL2, CD206, MHC class II, F4/80 and samples were collected with LSRII (BD Biosciences) and analyzed with FlowJo Software (Treestar, Ashland, OR).

### Mixed Chimera Transplants {#S24}

For mixed chimera transplants, mice were placed on oral antibiotics one week prior to transplantation. For transplant, mice were lethally irradiated by two exposures of 600cGy on the same day and transplanted within 24hrs of irradiation. Donor bone marrow cells (1.5 million cells / genotype, totaling 3 million cells / mouse) were injected retro-orbitally into anesthetized recipient mice. Transplanted mice were kept on oral antibiotics for 4 weeks after transplantation, and subsequently infected with *S. mansoni* or injected with *S. mansoni* eggs as described above.

RNA isolation and real-time quantitative PCR {#S25}
--------------------------------------------

For whole liver tissue analysis, representative pieces of liver were placed into Trizol™ (Ambion, Life Technologies) and homogenized. RNA was isolated from using the RNeasy mini-kit (Qiagen) as per the manufacturer's instructions. For analysis of sorted cells, Trizol™ was used to lyse the cells and RNA was isolated using either the RNeasy mini-kit (Qiagen) or RNeasy micro-kit (Qiagen) per the manufacturer's instructions. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed using the SYBR Green or Taqman qPCR kit (Applied Biosystems) and normalized to the housekeeping gene *Gapdh* by comparative Ct.

Tissue histological sections {#S26}
----------------------------

For immunofluorescence images, liver tissues were fixed in solution containing 0.05M phosphate buffer (pH7.4), 0.1M L-lysine and 10mg/ml paraformaldehyde overnight at 4°C. Fixed tissue was then equilibrated in 30% sucrose solution for 24hrs at 4°C and embedded in OCT and stored at -80°C. Tissues were then sectioned at a thickness of 10μm, mounted onto charged slides, allowed to dry, and dehydrated with an acetone wash. Sections were then stored at -80°C until staining. For staining, frozen sections were thawed and rehydrated in 80% ethanol prior to blocking with appropriate antibody-host serum. Sections were stained with rabbit anti-UCP1 (Abcam, ab10983) and Goat anti-rabbit F'ab fragments conjugated to Alexa Fluor 488 (Invitrogen, A-11008). EdU incorporation was stained by using the Click-it EdU Imaging kit (Life Technologies) per the manufacturers guidelines. For hematoxylin and eosin staining, formalin-fixed paraffin-embedded tissues were cut to a thickness of 10μm and stained. For preparation of liver containing *Brainbow2.1* fluorescence, anesthetized mice were perfused with 4%PFA via intracardial injection. Perfused livers were then cut using a vibratome (Leica) to obtain 200μm thick sections. Sections were then mounted onto positively charged slides, coverslipped with Vectashield™(Vector Labs) and sealed with nail polish, then stored at −20°C.

Microscopy {#S27}
----------

Acquisition of *Brainbow2.1* fluorescence was performed using the tile scanning feature of a Leica DM6000 upright confocal microscope. Tile scans were taken to a depth of 60μm and adjoining images were stitched together to form complete single images. Resulting images were then analyzed using the Fiji Image J software. For immunofluorescence imaging, stained sections were imaged using a Zeiss Axiovert fluorescence microscope. Processing of fluorescence images was performed using Fiji Image J software.

Statistical analysis {#S28}
--------------------

Results represent the mean s.e.m, statistical significance between groups was determined by unpaired Students T-test or analysis of variance (ANOVA) plus Bonferroni or Dunnett's correction for multiple comparisons. Statistical analysis was performed using GraphPad Prism v6.0. Researchers were not blinded to the groups, no exclusion criteria were applied and all samples were included in the analysis.

Accession codes {#S29}
---------------

Gene Expression Omnibus (GEO) SuperSeries accession number: GSE95003. This includes both RNA-seq data set (GSE95002) and ATACSeq (GSE95001) data.
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![Monocyte-derived inflammatory macrophages adopt a tissue resident phenotype after long-term residency in the peritoneal cavity\
(**a**) PD-L2 is rapidly downregulated while CD206 expression is retained on AAM^mono^. Adoptive transfer i.p.of thioglycollate + IL-4c elicited monocyte-derived macrophages from CD45.1 donor mice into CD45.2 recipient mice, rested for 24hrs and then treated +/- IL-4c prior to analysis. Representative FACS plots displaying expression of CD206, PD-L2, and F4/80 on Thio+IL-4c macrophages before transfer and gated on recipient (grey) or donor (blue) cells from recipient mice treated +/− IL-4c, 8 weeks after transfer. Representative histograms display surface expression of F4/80, CD206, PD-L2 in Donor CD45.1^+^ CD45.2^−^ (Black line) and recipient CD45.1^−^, CD45.2^+^ (Grey shaded) CD11b^+^, F4/80^+^ macrophages. (**b**) Long-term transfer of monocyte-derived inflammatory macrophages from CD45.1 donor mice treated with either thioglycollate or thioglycollate and IL-4c, into CD45.2 recipient mice and rested for 8 weeks prior to treatment with +/- IL- 4c. Representative histograms of CD206, PD-L2, and F4/80 expression on donor and recipient CD11b^+^ macrophages. (**c-d**) Increased proliferative capacity of macrophages after long-term residency. Representative FACS plots showing the frequency of EdU^+^ cells in recipient (Rec) and donor (Don) populations in response to IL-4c given after transfer of thioglycollate elicited (Thio) or (Thio+IL-4c) elicited macrophages and resting for 24hrs for short term residency (**c**) or long term residency for 8 weeks (**d**). (**e**) STAT6 is not required for conversion to a tissue resident phenotype. Representative expression of F4/80, CD206 and PD-L2 on donor CD45.2^+^ CD45.1^−^*Stat6^−/−^* (Black) and CD45.1^+^ CD45.2^−^ WT recipient (Grey shaded) CD11b^+^ cells. (**f**) IRF4 is not required for conversion to a tissue resident phenotype. Expression of F4/80, CD206, PD-L2 in donor CD45.2^+^ CD45.1^−^ (Black) and recipient CD45.2^−^, CD45.1^+^ (Grey shaded) CD11b^+^ cells.](nihms864511f1){#F1}

![Fate mapping monocyte derived macrophages adopting a tissue resident phenotype after long-term residency in the peritoneal cavity\
(**a**) Tamoxifen (TAM) pulse-administration and IL-4c treatment (i.p.) in *Cx3cr1^CreERT2-IRESYFP/+^Rosa26^floxed-tdTomato/+^* mice previously injected with thioglycollate at 1 week (n=4), 4 weeks (n=4) or 8 weeks (n=4) post-tamoxifen gavage. (**a--c**) Representative flow cytometric analysis of CD206 (**a**) or PD-L2 or MHCII (**b**) and F4/80 expression on (singlet, live, Siglec-F^−^) CD11b^+^ tdTomato^+^ cells (**a**) from *Cx3cr1^CreERT2-IRESYFP/+^ Rosa26^floxed-tdTomato/+^* mice injected with thioglycollate + IL- 4c and analyzed at 1, 4, and 8 weeks post-tamoxifen gavage. (**a**) Stacked bar graph showing the relative proportion of F4/80 and/or CD206 expression (**a**) in CD11b^+^ tdTomato^+^ cells, or (**c--d**) F4/80 and/or PDL2/MHCII expression. (**c**) Representative flow cytometry plots of PD-L2, CD206 and MHCII expression in CD11b^+^ tdTomato^+^ cells after IL-4c treatment in *Cx3cr1^CreERT2-IRESYFP/+^Rosa26^floxed-\ tdTomato/^*^+^ mice pulsed with TAM and injected with thioglycollate 4 weeks (n=6) or 8 weeks (n=3) prior. (**d**) Converted macrophages (AAM^conv^) gain expression of UCP1. Expression of UCP1 by RT-PCR on FACS sorted in CD11b^+^ tdTomato^+^CD206^+^F4/80^int^ 4 days after Thio+IL-4c treatment (AAM^mono^; n=3), relative to CD11b^+^ tdTomato^−^CD206^−^F4/80^high^ cells from naïve *Cx3cr1^CreERT2-IRESYFP/+^Rosa26^floxed-\ tdTomato/+^* mice treated with IL-4c only (AAM^res^; n=6) and CD11b^+^ tdTomato^+^ CD206^−^F4/80^high^ cells 8 weeks post thioglycollate treatment (AAM^conv^; n=8).](nihms864511f2){#F2}

![Transcriptional and chromatin landscape re-programming during macrophage conversion\
(**a**) Representative flow plots showing gating strategies for three different populations of macrophages (AAM^mono^: n=3, AAM^res^: n=3, AAM^conv^, n=3). (**b**) Pairwise Euclidean distance with respect to the transcriptional profiles from each sample showing AAM^conv^ transcriptionally resembles AAM^res^. (**c**) MA plots of differential analyses comparing the transcriptional profiles of AAM^conv^ to that of AAM^mono^ and AAM^res^, respectively. Differential genes (FDR 10%, \|LFC\| \> 0) are highlighted in red. (**d**) GO analysis of genes upregulated in AAM^conv^ when compared to AAM^mono^ (top), as well as genes downregulated in AAM^conv^ when compared to AAM^res^ (bottom). (**e**) Clustering of rlog-transformed read counts of expressed genes in AAM^mono^, AAM^res^ and AAM^conv^ showing 5 different clusters of genes (C1--C5). (**f**) Pairwise Euclidean distance with respect to the accessible REs from each sample showing the open chromatin landscape in AAM^conv^ resembles that of AAM^res^. (**g**) MA plots of differential analyses comparing the accessible Res in AAM^conv^ to that of AAM^mono^ and AAM^res^, respectively. Differential regions (FDR 10%, \|LFC\| \> 0) are highlighted in red. (**h**) Genome browser views of the *Pdcd1lg2* (PDL2), *Ucp1* and *Gata6* gene bodies in AAM^mono^ (red track), AAM^conv^ (blue track) and AAM^res^ (orange track). Each track represents normalized read counts of accessible chromatin regions. (**i**) Clustering of rlog-transformed read counts of accessible REs in AAM^mono^, AAM^res^ and AAM^conv^ showing 3 different clusters of REs (C1--C3).](nihms864511f3){#F3}

![Vitamin A deficiency disrupts tissue resident macrophages\
Peritoneal macrophages were evaluated from either vitamin A deficient (Vit-A^DEF^) mice or control (Vit-A^CON^) mice after treatment with IL-4c or without treatment. Representative FACS plots for (**a**) Flow cytometry analysis of peritoneal macrophage Vit-A^DEF^(n=7) and Vit-A^CON^(n=7) mice. Stacked bar graph shows increased frequencies of F4/80^+^ CD206^+^and F4/80^+^ CD206^−^expressing CD11b^+^populations; and (**b**) Flow cytometry analysis of peritoneal macrophages from Vit-A^DEF^(n=5) and Vit-A^CON^(n=5) mice. Stacked bar graph shows increased frequencies PD-L2 and F4/80 expression. (**c**) EdU incorporation from peritoneal macrophages of IL-4c treatedVit-A^DEF^(n=8) and Vit-A^CON^(n=6) mice. (**d**) Vit-A^DEF^mice were treated with all-trans RA every 2 days for 14 days prior to IL-4c treatment. Representative FACS plots of PD-L2 expression in peritoneal macrophages of Vit-A^CON^(n=5), Vit-A^DEF^(n=5), and Vit-A^DEF^mice treated with all-trans RA (ATRA) (n=5). Stacked bar graph indicates frequencies of F4/80 and PD-L2 in CD11b^+^ cells. \*\*P \< 0.01. Unpaired Students T-test.](nihms864511f4){#F4}

![Phenotypic conversion of inflammatory macrophages to a tissue resident phenotype is disrupted in Vitamin A-deficient mice\
(**a**) Long-term transfer of monocyte-derived inflammatory macrophages from thioglycollate treated CD45.1 donor mice into CD45.2 recipient vitamin A deficient (Vit-A^DEF^) mice or control (Vit-A^CON^) mice, rested for 8 weeks and subsequently treated with IL-4c. Naïve CD45.1 mice were also treated with IL-4c (**a**) Representative FACS plots of F4/80^+^ CD45.1^+^ events and (**b**) PD-L2 and CD206 expression in CD45.1 cells after 8 weeks post reconstitution in Vit-A^CON^(n=5) or Vit-A^DEF^(n=5) mice. (**c**) Flow cytometry analysis of mean fluorescence intensity for F4/80, CD206, PD-L2 and MHCII in CD45.1 peritoneal macrophages. (**d**) Quantification of mean fluorescence intensities of F4/80, CD206, PD-L2 and MHCII in CD45.1 macrophages from Vit-A^CON^(n=5) or Vit-A^DEF^ (n=7) mice. (**e**) Representative flow cytometry plots of CD206 and F4/80 frequencies in tdTomato+ peritoneal macrophages from Vit-A^CON^(n=9), Vit-A^DEF^(n=9) or Vit-A^DEF^ mice switched onto Vit-A^CON^ diet (Vit-A^DEF→CON^;n=3). (**f**) Stacked bar graph represents frequencies of F4/80 and CD206 from CD11b^+^ tdTomato^+^ cells. (**g**) RT-PCR analysis of *Ucp1* and *Gata6* expression in CD11b^+^ tdTomato^+^ peritoneal macrophages from (**e**) normalized to expression of GAPDH. Graphs depict mean ± standard error of the mean of individual mice pooled from 2 independent experiments. Data shown are the mean and s.e.m. ns = not significant, \*P\<0.05, \*\*\*P\<0.001 unpaired Students T-test.](nihms864511f5){#F5}

![Increased *Ucp1* expression and proliferation in mature egg liver granulomas of *S. mansoni* infected mice\
(**a**) Transcript expression of *Ucp1* in whole liver from mice infected with S. mansoni at 8 weeks post infection (**b**) Time course of *Ucp1* expression in the liver during *S. mansoni* infection. (**c**) Flow cytometric analysis showing the frequency of EdU^+^ F4/80^+^ cells from *S. mansoni* infected liver at the indicated time point. (**d**) Quantification of EdU^+^ F4/80^+^ cells at different time points during *S. mansoni* infection. (**e**) Representative immunofluorescence images of *S. mansoni*-infected liver mature granulomas stained with anti-UCP1 (green), and Click-it EdU (red). (**f**) Representative immunofluorescence images of *S. mansoni*-infected liver granulomas at different timepoints post infection stained with DAPI (blue) and Click-it EdU (red) taken from mice pulsed with EdU 3 hours prior to sacrifice. Eggs are outlined in white and scale bars represent 50 microns. (**g**) TAM pulse experiments with *Cx3cr1^CreERT2-IRESYFP/+^Rosa26^Brainbow2.1/+^* mice infected with *S. mansoni*. Confocal images of immature granulomas (left) or mature granulomas (right) from livers of *Cx3cr1^CreERT2-IRESYFP/+^Rosa26^Brainbow2.1/+^* mice infected with *S. mansoni* at 12 weeks post-infection given tamoxifen 1 week or 5 weeks prior to the sac. Scale bars = 50μm. XY scatter plots represent approximate localization of Brainbow2.1 fluorescent cells within above image. \*\*P\<0.01, \*\*\*P\<0.001, unpaired Students T test.](nihms864511f6){#F6}

![Fate mapping monocyte-derived macrophages in the liver granulomas of *S. mansoni* infected mice\
(**a**) TAM pulse administration via oral gavage in the *S. mansoni* infected *Cx3cr1^CreER-IRESYFP/+^Rosa26^floxed-tdTomato/+^* mice. Representative gating scheme for tdTomato^+^ monocyte-derived macrophages in the liver (singlet, live, Siglec-F^−^, CD11b^+^) in TAM treated *Cx3cr1^CreERT2-IRESYFP/+^ Rosa26^floxed-tdTomato/+^* mice infected with *S. mansoni*. (**b**) Quantitation of tdTomato^+^ cells reveals rapid turnover of CX~3~CR1^+^ derived cells during *S. mansoni* infection. Graph indicates percentage of CD11b^+^ tdTomato^+^ cells after 1, 2, or 5 weeks post-TAM gavage. (**c**) Representative flow cytometry plots of YFP^+^ and/or tdTomato^+^ cells isolated from the liver of *Cx3cr1^CreERT2-IRESYFP/+^Rosa26^floxed−\ tdTomato/+^* mice infected with *S. mansoni* after 1 week, 2 weeks or 5 weeks post- tamoxifen gavage. (**d**) Representative flow cytometry plots of PD-L2 and CD206 expression in CD11b^+^ cells based on the YFP and/or tdTomato expression. (**e**) Quantification of the frequency of F4/80^+^ CD206^+^ or F4/80^+^ PD-L2^+^ cells (gated on single, live, Siglec-F^−^, CD11b^+^) after 1 week (n=8), 2 weeks (n=3) or 5 weeks (n=10) post-tamoxifen gavage. (**f**) *Ucp1* mRNA expression in sorted CX~3~CR1-YFP^+^ and/or tdTomato^+^ cells from *Cx3cr1^CreERT2-IRESYFP/+Rosa26floxed-tdTomato/+^* mice infected with *S. mansoni* given a TAM pulse 5 weeks prior (left) or from mice on TAM diet for 6 weeks (right). (**g**) *Cx3cr1^CreERT2-IRESYFP/+^ Rosa26^floxed-tdTomato/+^* mice infected with *S. mansoni* given tamoxifen (TAM) diet for 2 weeks Increased accumulation of tdTomato^+^ cells that have downregulated YFP expression at 2 weeks (n=3) or 6 weeks (n=5). (**h**) Quantification of CD11b^+^ event frequencies after 2 weeks or 6 weeks TAM diet of F4/80^+^ CD206^+^, F4/80^+^ PD-L2^+^, or F4/80^+^ MHCII^+^ events. \*\*P\<0.01, \*\*\*P\<0.001, unpaired Students T test.](nihms864511f7){#F7}

![Disruption of Ucp1 expression and proliferation in granulomas and increased mortality of *S. mansoni* infection in vitamin A-deficient mice\
**(a)** Vitamin A deficient (Vit-A^DEF^) or control (Vit-A^CON^) mice infected with *S. mansoni* and treated with all-*trans* RA starting at 5 weeks post-infection, every other day for 14 days. Mice were sacrificed at 7.5 weeks post infection. Survival curve of Vit-A^CON^ (n=32) and Vit-A^DEF^ (n=28) mice infected with *S. mansoni*. (**b**) RT-PCR analysis of *Ucp1* and *Gata6* expression in the liver of *S. mansoni* infected Vit-A^CON^(n=15), Vit-A^DEF^(n=11) or Vit-A^DEF^ treated with all-*trans* RA (ATRA) (n=4) mice normalized to expression of GAPDH. Graphs depict mean ± standard error of the mean of individual mice pooled from 3 independent experiments. **(c)** Representative images from immunofluorescence microscopy of liver granulomas from Vit-A^CON^and Vit-A^DEF^infected with *S. mansoni* stained for EdU (red) UCP1 (green). (**d-h**) Analysis results for *S. mansoni* infected Vit-A^CON^(n=8), Vit-A^DEF^(n=8), and Vit-A^DEF^mice treated with ATRA (n=4). (**d**) Representative FACS plots of CD206, PD-L2 expression of macrophages. (**e**) Stacked bar graph indicates frequencies of F4/80 and PD-L2 in CD11b^+^ cells. (**f**) Representative FACS plots of Siglec-F^+^ eosinophils. Quantification of Siglec-F^+^ cells. Scale bar 50μm. \**P* \< 0.05 and \*\*P\<0.01 \*\*\**P* \< 0.0001. One-way ANOVA with Bonferroni post-test correction. Data representative of two independent experiments involving 5 to 6 mice per group.](nihms864511f8){#F8}

[^1]: Equal contributing authors
